AXITINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 412 adverse event reports in the FDA FAERS database where AXITINIB was used for Neoplasm malignant.
Most Reported Side Effects for AXITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,222 | 14.0% | 2,212 | 148 |
| Diarrhoea | 2,187 | 13.8% | 121 | 539 |
| Fatigue | 1,816 | 11.5% | 102 | 340 |
| Neoplasm progression | 1,315 | 8.3% | 354 | 236 |
| Hypertension | 1,146 | 7.2% | 78 | 320 |
| Off label use | 1,075 | 6.8% | 338 | 178 |
| Nausea | 955 | 6.0% | 74 | 225 |
| Decreased appetite | 920 | 5.8% | 123 | 283 |
| Dysphonia | 871 | 5.5% | 55 | 184 |
| Disease progression | 768 | 4.8% | 242 | 171 |
| Blood pressure increased | 756 | 4.8% | 45 | 166 |
| Weight decreased | 695 | 4.4% | 61 | 184 |
| Asthenia | 629 | 4.0% | 81 | 232 |
| Stomatitis | 514 | 3.2% | 44 | 107 |
| Headache | 504 | 3.2% | 19 | 116 |
Other Indications for AXITINIB
Renal cancer (3,422)
Renal cell carcinoma (2,447)
Metastatic renal cell carcinoma (1,612)
Clear cell renal cell carcinoma (480)
Renal cancer metastatic (456)
Product used for unknown indication (223)
Renal cell carcinoma stage iv (176)
Renal cancer stage iv (96)
Metastases to lung (82)
Lung neoplasm malignant (67)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)